Pure Global

Influenza A/B virus nucleic acid IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Influenza A/B virus nucleic acid IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 108740. The device is manufactured by Credo Diagnostics Biomedical Pte. Ltd. Taiwan branch from Taiwan, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Advena Ltd.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Influenza A/B virus nucleic acid IVD, kit, nucleic acid technique (NAT)
MHRA Device ID: 108740โ€ขRef: 108740

Device Type

In Vitro Diagnostic Device

Devices

Influenza A/B virus nucleic acid IVD, kit, nucleic acid technique (NAT)

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Nov 8, 2024

Manufacturer Information

Address

(Building D) 15F., No.93, Sec.1, Xintai 5th Road

New taipei city , Xizhi District, Taiwan

Created Date

Aug 31, 2021

Authorized Representative

Relationship Type

UK Responsible Person

Address

Pure Offices Plato Close

Warwick, England, United Kingdom

Postcode: CV34 6WE

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing